Skip to main navigation
Skip to search
Skip to main content
Hamad Bin Khalifa University Home
Home
Profiles
Research units
Projects
Research output
Activities
Student theses
Search by expertise, name or affiliation
Cerebrospinal fluid biomarkers in Parkinson disease
Lucilla Parnetti
*
, Anna Castrioto
, Davide Chiasserini
, Emanuele Persichetti
, Nicola Tambasco
,
Omar El-Agnaf
, Paolo Calabresi
*
Corresponding author for this work
University of Perugia
VU University Medical Center
United Arab Emirates University
University Hospital of Perugia
Research output
:
Contribution to journal
›
Review article
›
peer-review
186
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cerebrospinal fluid biomarkers in Parkinson disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Parkinson's Disease
100%
Cerebrospinal Fluid Biomarkers
100%
Cerebrospinal Fluid
33%
Disease Progression
16%
Molecular Pathways
16%
Clinical Diagnosis
16%
Early Disease
16%
Novel Biomarkers
16%
Biomarkers for Early Diagnosis
16%
Neurodegenerative Diseases
16%
Alpha-synuclein (α-syn)
16%
High Risk
16%
Preclinical Stage
16%
Diagnostic Accuracy
16%
Early Monitoring
16%
Study Support
16%
Fluid Level
16%
Amyloid-β Peptide
16%
Disease-modifying Therapy
16%
Early Therapy
16%
Brain-inspired
16%
DJ-1
16%
Molecular Changes
16%
Biochemistry, Genetics and Molecular Biology
Preclinical Study
25%
Derived Protein
25%
Neuroscience
Protein Deglycase DJ-1
20%